Article Information
History
- November 3, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Guillermo Barturen1,*,
- Elena Carnero-Montoro1,
- Manuel Martínez-Bueno1,
- Silvia Rojo-Rello2,
- Beatriz Sobrino3,
- Clara Alcántara-Domínguez4,
- David Bernardo5,6 and
- Marta E. Alarcón-Riquelme1,7,*
- 1GENYO. Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government. Granada, Spain
- 2Servicio de Microbiología e Inmunología. Hospital Clínico Universitario de Valladolid. Valladolid, Spain
- 3Servicio de Enfermedades Infecciosas. Hospital Regional de Málaga. Málaga, Spain
- 4Lorgen G.P., S.L., Business Innovation Center - BIC/CEEL, Technological Area of Health Science, Granada, Spain
- 5Mucosal Immunology Lab. Unidad de Excelencia Instituto de Biomedicina y Genética Molecular de Valladolid (IBGM, Universidad de Valladolid-CSIC). Valladolid, Spain
- 6Centro de Investigaciones Biomédicas en Red de Enfermedades Hepáticas y Digestivas (CIBERehd). Madrid, Spain
- 7Unit of Inflammatory Chronic Diseases, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- ↵*Correspondence: Guillermo Barturen and Marta E. Alarcón-Riquelme: GENYO. Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, Av de la Ilustración 114, Parque Tecnológico de la Salud, 18016, Granada, Spain. guillermo.barturen{at}genyo.es and marta.alarcon{at}genyo.es
Posted November 03, 2021.
Whole-Blood DNA Methylation Analysis Reveals Respiratory Environmental Traits Involved in COVID-19 Severity Following SARS-CoV-2 Infection
